Cite
HARVARD Citation
Mofors, J. et al. (2019). Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome. Journal of internal medicine. pp. 458-468. [Online].